INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH-RISK PROGNOSTIC FACTORS.

Published in:

Hematological Oncology, 2017, v. 35, p. 109, doi. 10.1002/hon.2437_99

By:

• Kipps, T.J.;
• Fraser, G.;
• Coutre, S.E.;
• Brown, J.R.;
• Barrientos, J.C.;
• Barr, P.M.;
• Byrd, J.C.;
• O'Brien, S.M.;
• Dilhuydy, M.;
• Hillmen, P.;
• Jaeger, U.;
• Moreno, C.;
• Cramer, P.;
• Stilgenbauer, S.;
• Chanan ‐ Khan, A.A.;
• Mahler, M.;
• Salman, M.;
• Cheng, M.;
• Londhe, A.;
• Ninomoto, J.

Publication type:

Article